Allowed Publications
Federal Practitioner
Slot System
Featured Buckets
Featured Buckets Admin

Effects of Statins in Type 2 Diabetes

Article Type
Article
Changed
Display Headline
Effects of Statins in Type 2 Diabetes

Article PDF
022030047_2.pdf
Author and Disclosure Information

Issue
Federal Practitioner - 22(3)
Publications
Federal Practitioner
Type 2 Diabetes ICYMI
Topics
Cardiology
Diabetes
Page Number
48
Legacy Keywords
statins, diabetes, type 2 diabetes, cardiovasular diseasestatins, diabetes, type 2 diabetes, cardiovasular disease
Sections
Pharmacology
Author and Disclosure Information

Author and Disclosure Information

Article PDF
022030047_2.pdf
Article PDF
022030047_2.pdf

Issue
Federal Practitioner - 22(3)
Issue
Federal Practitioner - 22(3)
Page Number
48
Page Number
48
Publications
Federal Practitioner
Type 2 Diabetes ICYMI
Publications
Federal Practitioner
Type 2 Diabetes ICYMI
Topics
Cardiology
Diabetes
Article Type
Article
Display Headline
Effects of Statins in Type 2 Diabetes
Display Headline
Effects of Statins in Type 2 Diabetes
Legacy Keywords
statins, diabetes, type 2 diabetes, cardiovasular diseasestatins, diabetes, type 2 diabetes, cardiovasular disease
Legacy Keywords
statins, diabetes, type 2 diabetes, cardiovasular diseasestatins, diabetes, type 2 diabetes, cardiovasular disease
Sections
Pharmacology
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

AD and Anticholinergics Don't Mix

Article Type
Article
Changed
Display Headline
AD and Anticholinergics Don't Mix

Article PDF
022030047_1.pdf
Author and Disclosure Information

Issue
Federal Practitioner - 22(3)
Publications
Federal Practitioner
Page Number
47
Legacy Keywords
AD, Alzheimer's disease, adverse drug effects, neurology, anticholinergics, dementiaAD, Alzheimer's disease, adverse drug effects, neurology, anticholinergics, dementia
Sections
Pharmacology
Author and Disclosure Information

Author and Disclosure Information

Article PDF
022030047_1.pdf
Article PDF
022030047_1.pdf

Issue
Federal Practitioner - 22(3)
Issue
Federal Practitioner - 22(3)
Page Number
47
Page Number
47
Publications
Federal Practitioner
Publications
Federal Practitioner
Article Type
Article
Display Headline
AD and Anticholinergics Don't Mix
Display Headline
AD and Anticholinergics Don't Mix
Legacy Keywords
AD, Alzheimer's disease, adverse drug effects, neurology, anticholinergics, dementiaAD, Alzheimer's disease, adverse drug effects, neurology, anticholinergics, dementia
Legacy Keywords
AD, Alzheimer's disease, adverse drug effects, neurology, anticholinergics, dementiaAD, Alzheimer's disease, adverse drug effects, neurology, anticholinergics, dementia
Sections
Pharmacology
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Epilepsy Drugs and Fracture Risk

Article Type
Article
Changed
Display Headline
Epilepsy Drugs and Fracture Risk

Article PDF
022030047_0.pdf
Author and Disclosure Information

Issue
Federal Practitioner - 22(3)
Publications
Federal Practitioner
Page Number
47
Legacy Keywords
epilepsy, fracture risk, adverse drug effects, interactions, drugs, treatment, bone lossepilepsy, fracture risk, adverse drug effects, interactions, drugs, treatment, bone loss
Sections
Pharmacology
Author and Disclosure Information

Author and Disclosure Information

Article PDF
022030047_0.pdf
Article PDF
022030047_0.pdf

Issue
Federal Practitioner - 22(3)
Issue
Federal Practitioner - 22(3)
Page Number
47
Page Number
47
Publications
Federal Practitioner
Publications
Federal Practitioner
Article Type
Article
Display Headline
Epilepsy Drugs and Fracture Risk
Display Headline
Epilepsy Drugs and Fracture Risk
Legacy Keywords
epilepsy, fracture risk, adverse drug effects, interactions, drugs, treatment, bone lossepilepsy, fracture risk, adverse drug effects, interactions, drugs, treatment, bone loss
Legacy Keywords
epilepsy, fracture risk, adverse drug effects, interactions, drugs, treatment, bone lossepilepsy, fracture risk, adverse drug effects, interactions, drugs, treatment, bone loss
Sections
Pharmacology
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Osteonecrosis and HAART

Article Type
Article
Changed
Display Headline
Osteonecrosis and HAART

Article PDF
022030047.pdf
Author and Disclosure Information

Issue
Federal Practitioner - 22(3)
Publications
Federal Practitioner
Topics
HIV
Page Number
47
Legacy Keywords
HAART, highly active antiretroviral therapy, osteonecrosis, avascular necrosis of bone, AVNHAART, highly active antiretroviral therapy, osteonecrosis, avascular necrosis of bone, AVN
Sections
Pharmacology
Author and Disclosure Information

Author and Disclosure Information

Article PDF
022030047.pdf
Article PDF
022030047.pdf

Issue
Federal Practitioner - 22(3)
Issue
Federal Practitioner - 22(3)
Page Number
47
Page Number
47
Publications
Federal Practitioner
Publications
Federal Practitioner
Topics
HIV
Article Type
Article
Display Headline
Osteonecrosis and HAART
Display Headline
Osteonecrosis and HAART
Legacy Keywords
HAART, highly active antiretroviral therapy, osteonecrosis, avascular necrosis of bone, AVNHAART, highly active antiretroviral therapy, osteonecrosis, avascular necrosis of bone, AVN
Legacy Keywords
HAART, highly active antiretroviral therapy, osteonecrosis, avascular necrosis of bone, AVNHAART, highly active antiretroviral therapy, osteonecrosis, avascular necrosis of bone, AVN
Sections
Pharmacology
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

DHEA to Treat Middle-Age Spread?

Article Type
Article
Changed
Display Headline
DHEA to Treat Middle-Age Spread?

Article PDF
022020062_5.pdf
Author and Disclosure Information

Issue
Federal Practitioner - 22(2)
Publications
Federal Practitioner
Page Number
70
Legacy Keywords
DHEA, dehydroepiandrosterone, obesityDHEA, dehydroepiandrosterone, obesity
Sections
Pharmacology
Author and Disclosure Information

Author and Disclosure Information

Article PDF
022020062_5.pdf
Article PDF
022020062_5.pdf

Issue
Federal Practitioner - 22(2)
Issue
Federal Practitioner - 22(2)
Page Number
70
Page Number
70
Publications
Federal Practitioner
Publications
Federal Practitioner
Article Type
Article
Display Headline
DHEA to Treat Middle-Age Spread?
Display Headline
DHEA to Treat Middle-Age Spread?
Legacy Keywords
DHEA, dehydroepiandrosterone, obesityDHEA, dehydroepiandrosterone, obesity
Legacy Keywords
DHEA, dehydroepiandrosterone, obesityDHEA, dehydroepiandrosterone, obesity
Sections
Pharmacology
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Rosiglitazone to Prevent Restenosis

Article Type
Article
Changed
Display Headline
Rosiglitazone to Prevent Restenosis

Article PDF
022020062_4.pdf
Author and Disclosure Information

Issue
Federal Practitioner - 22(2)
Publications
Federal Practitioner
Type 2 Diabetes ICYMI
Topics
Cardiology
Diabetes
Page Number
63
Legacy Keywords
rosiglitazone, restenosis, cardiovascular disease, diabetesrosiglitazone, restenosis, cardiovascular disease, diabetes
Sections
Pharmacology
Author and Disclosure Information

Author and Disclosure Information

Article PDF
022020062_4.pdf
Article PDF
022020062_4.pdf

Issue
Federal Practitioner - 22(2)
Issue
Federal Practitioner - 22(2)
Page Number
63
Page Number
63
Publications
Federal Practitioner
Type 2 Diabetes ICYMI
Publications
Federal Practitioner
Type 2 Diabetes ICYMI
Topics
Cardiology
Diabetes
Article Type
Article
Display Headline
Rosiglitazone to Prevent Restenosis
Display Headline
Rosiglitazone to Prevent Restenosis
Legacy Keywords
rosiglitazone, restenosis, cardiovascular disease, diabetesrosiglitazone, restenosis, cardiovascular disease, diabetes
Legacy Keywords
rosiglitazone, restenosis, cardiovascular disease, diabetesrosiglitazone, restenosis, cardiovascular disease, diabetes
Sections
Pharmacology
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Lisinopril and Tizanidine: Potential for Trouble

Article Type
Article
Changed
Display Headline
Lisinopril and Tizanidine: Potential for Trouble

Article PDF
022020062_3.pdf
Author and Disclosure Information

Issue
Federal Practitioner - 22(2)
Publications
Federal Practitioner
Page Number
63
Legacy Keywords
lisinopril, tizanidine, hypertension, adverse drug effects, interactionslisinopril, tizanidine, hypertension, adverse drug effects, interactions
Sections
Pharmacology
Author and Disclosure Information

Author and Disclosure Information

Article PDF
022020062_3.pdf
Article PDF
022020062_3.pdf

Issue
Federal Practitioner - 22(2)
Issue
Federal Practitioner - 22(2)
Page Number
63
Page Number
63
Publications
Federal Practitioner
Publications
Federal Practitioner
Article Type
Article
Display Headline
Lisinopril and Tizanidine: Potential for Trouble
Display Headline
Lisinopril and Tizanidine: Potential for Trouble
Legacy Keywords
lisinopril, tizanidine, hypertension, adverse drug effects, interactionslisinopril, tizanidine, hypertension, adverse drug effects, interactions
Legacy Keywords
lisinopril, tizanidine, hypertension, adverse drug effects, interactionslisinopril, tizanidine, hypertension, adverse drug effects, interactions
Sections
Pharmacology
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Comparing Effects of Daily and Twice Weekly Simvastatin

Article Type
Article
Changed
Display Headline
Comparing Effects of Daily and Twice Weekly Simvastatin

Article PDF
022020062_1.pdf
Author and Disclosure Information

Issue
Federal Practitioner - 22(2)
Publications
Federal Practitioner
Topics
Cardiology
Page Number
62
Legacy Keywords
cholesterol, simvastatin, cardiovascular diseasecholesterol, simvastatin, cardiovascular disease
Sections
Pharmacology
Author and Disclosure Information

Author and Disclosure Information

Article PDF
022020062_1.pdf
Article PDF
022020062_1.pdf

Issue
Federal Practitioner - 22(2)
Issue
Federal Practitioner - 22(2)
Page Number
62
Page Number
62
Publications
Federal Practitioner
Publications
Federal Practitioner
Topics
Cardiology
Article Type
Article
Display Headline
Comparing Effects of Daily and Twice Weekly Simvastatin
Display Headline
Comparing Effects of Daily and Twice Weekly Simvastatin
Legacy Keywords
cholesterol, simvastatin, cardiovascular diseasecholesterol, simvastatin, cardiovascular disease
Legacy Keywords
cholesterol, simvastatin, cardiovascular diseasecholesterol, simvastatin, cardiovascular disease
Sections
Pharmacology
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Determining Length of Treatment for Major Depression

Article Type
Article
Changed
Display Headline
Determining Length of Treatment for Major Depression

Article PDF
022020062_0.pdf
Author and Disclosure Information

Issue
Federal Practitioner - 22(2)
Publications
Federal Practitioner
Page Number
62
Legacy Keywords
major depression, depression, treatment, antidepressants, cognitive behavioral therapymajor depression, depression, treatment, antidepressants, cognitive behavioral therapy
Sections
Pharmacology
Author and Disclosure Information

Author and Disclosure Information

Article PDF
022020062_0.pdf
Article PDF
022020062_0.pdf

Issue
Federal Practitioner - 22(2)
Issue
Federal Practitioner - 22(2)
Page Number
62
Page Number
62
Publications
Federal Practitioner
Publications
Federal Practitioner
Article Type
Article
Display Headline
Determining Length of Treatment for Major Depression
Display Headline
Determining Length of Treatment for Major Depression
Legacy Keywords
major depression, depression, treatment, antidepressants, cognitive behavioral therapymajor depression, depression, treatment, antidepressants, cognitive behavioral therapy
Legacy Keywords
major depression, depression, treatment, antidepressants, cognitive behavioral therapymajor depression, depression, treatment, antidepressants, cognitive behavioral therapy
Sections
Pharmacology
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

HRT and Ovarian Cancer: How Does Dose Affect Risk?

Article Type
Article
Changed
Display Headline
HRT and Ovarian Cancer: How Does Dose Affect Risk?

Article PDF
022020062.pdf
Author and Disclosure Information

Issue
Federal Practitioner - 22(2)
Publications
AVAHO
Federal Practitioner
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Oncology
Page Number
62
Legacy Keywords
HRT, hormone replacement therapy, ovarian cancer, cancer, hysterectomyHRT, hormone replacement therapy, ovarian cancer, cancer, hysterectomy
Sections
Pharmacology
Clinical Topics & News
Author and Disclosure Information

Author and Disclosure Information

Article PDF
022020062.pdf
Article PDF
022020062.pdf

Issue
Federal Practitioner - 22(2)
Issue
Federal Practitioner - 22(2)
Page Number
62
Page Number
62
Publications
AVAHO
Federal Practitioner
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Publications
AVAHO
Federal Practitioner
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Oncology
Article Type
Article
Display Headline
HRT and Ovarian Cancer: How Does Dose Affect Risk?
Display Headline
HRT and Ovarian Cancer: How Does Dose Affect Risk?
Legacy Keywords
HRT, hormone replacement therapy, ovarian cancer, cancer, hysterectomyHRT, hormone replacement therapy, ovarian cancer, cancer, hysterectomy
Legacy Keywords
HRT, hormone replacement therapy, ovarian cancer, cancer, hysterectomyHRT, hormone replacement therapy, ovarian cancer, cancer, hysterectomy
Sections
Pharmacology
Clinical Topics & News
Article Source

PURLs Copyright

Inside the Article

Article PDF Media
Subscribe to Pharmacology